Consumer healthcare company Geyser Brands (TSX.V: GYSR) recently announced its successful first test harvest and second harvest as a cannabis cultivator in accordance with Health Canada’s license to cultivate. The company anticipates a 200% yield increase over the first two harvests for its third harvest, which is currently in the ground. A recent article discussing the company reads, “Geyser Brands is a British Columbia-based company producing consumer health care products and brands through a formulation laboratory focused on enhancing the bioavailability and shelf stability of all-natural, hemp-derived cannabidiol (CBD) products. The company’s proprietary NanoFusion technology is at the heart of its topical, cream, beverage and baked goods, oil and tincture formulations for promoting human and pet health. Its strategy is to build and market brands nationally and internationally, establishing retail channels and direct-to-consumer experiences for its hemp-infused products and enhancing the products with CBD where legal. . . . Geyser began trading on the TSX Venture Exchange in December, and with its first and second harvests under its belt (http://nnw.fm/B7Xu5), the company is working to complete a processing and sales license, which will allow GYSR to extend its products into the regulated Canadian cannabis market and direct-to-consumer medical market.”
To view the full article, visit http://nnw.fm/cYt6T
About Geyser Brands Inc.
Geyser Brands builds health-based, hemp-CBD consumer products in the nutraceutical, cosmetics, food-and-beverage and pet sectors worldwide. R&D investment in NanoFusion, a proprietary all-natural nanotechnology, delivers topical, cream, beverages and baked goods, oil, and tincture formulations with superior bioavailability and water solubility. Geyser Brands is a Health Canada-approved Licensed Producer (“LP”) in Port Coquitlam, British Columbia, that holds a cultivation license and is anticipating its processing and sales licenses. The company is exclusively focusing on leveraging these assets to provide the regulatory infrastructure for its global brands and distribution strategy, acquiring hemp- and plant-based brands and infusing them with new CBD product lines in jurisdictions where the therapeutic ingredient is legal. The company’s proprietary NanoFusion technology surrounds oils and solves for the insolubility of CBD. Geyser Brands will utilize its 7,000-square-foot licensed facility in British Columbia for the manufacturing and distribution of its hemp and CBD-based products internationally. For more information, visit the company’s website at www.GeyserBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://nnw.fm/GYSR
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]